XML 31 R15.htm IDEA: XBRL DOCUMENT
v3.23.1

Note 9 - Other Intangible Assets | 12 Months Ended
--- | ---
Dec. 31, 2022
Notes to Financial Statements |
Intangible Assets Disclosure [Text Block] | NOTE 9. OTHER INTANGIBLE ASSETS For the years ended December 31, 2022 and 2021, other intangible assets consisted of the following (in thousands):
|  | Balance at December 31, 2022 |
|  |  |  |  |  | Accumulated |  |  |  |  |  |  |  |  |
|  | Gross |  |  | Amortization |  |  | Impairment |  |  | Net |
Indefinite-lived intangible assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trade names |  | $ | 2,080 |  |  | $ | — |  |  | $ | (970 | ) |  | $ | 1,110 |
Amortizable intangible assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Customer relationships |  | $ | 290 |  |  | $ | (48 | ) |  | $ | (172 | ) |  | $ | 70 |
Trade secrets / product formulations |  |  | 2,890 |  |  |  | (375 | ) |  | $ | (1,415 | ) |  |  | 1,100 |
Total other intangible assets |  | $ | 5,260 |  |  | $ | (423 | ) |  | $ | (2,557 | ) |  | $ | 2,280 |
|  | Balance at December 31, 2021 |
|  |  |  |  |  | Accumulated |  |  |  |  |  |  |  |  |
|  | Gross |  |  | Amortization |  |  | Impairment |  |  | Net |
Indefinite-lived intangible assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trade names |  | $ | 2,080 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,080 |
Amortizable intangible assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Customer relationships |  | $ | 290 |  |  | $ | (7 | ) |  | $ | — |  |  | $ | 283 |
Trade secrets / product formulations |  |  | 2,890 |  |  |  | (53 | ) |  |  | — |  |  |  | 2,837 |
Total other intangible assets |  | $ | 5,260 |  |  | $ | (60 | ) |  | $ | — |  |  | $ | 5,200 |
In the fourth quarter of 2022, the Company determined that certain of its indefinite-lived and long-lived amortizable intangible assets related to its DERMAdoctor business were impaired. As such, the Company has recorded an intangible asset impairment charge of $2.6 million in the year ended December 31, 2022, which is reflected in the goodwill, intangible and other asset impairment caption in the Company’s consolidated statements of operations. The impairment information is discussed in Note 2, “Summary of Significant Account Policies,”. The Company did not record any intangible asset impairment charges for the year ended December 31, 2021. Amortization expense was $363 thousand and $60 thousand for the years ended December 31, 2022 and 2021, respectively. Based on the amortizable intangible assets as of December 31, 2022, future amortization expenses is expected to be as follows (in thousands):
2023 |  | $ | 152 |
2024 |  |  | 153 |
2025 |  |  | 152 |
2026 |  |  | 153 |
Thereafter |  |  | 560 |
Total |  | $ | 1,170 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -URI https://asc.fasb.org/subtopic&trid=2144471 + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration